Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_3
5
83%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 35 (83.3%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation

NCT00396877
completedphase_3

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

NCT00862420
completedphase_3

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

NCT00050817
completedphase_3

Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned

NCT00821834
completedphase_3

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

NCT00714961
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00396877Phase 3

Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation

Completed
NCT00862420Phase 3

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

Completed
NCT00050817Phase 3

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Completed
NCT00821834Phase 3

Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned

Completed
NCT00714961Phase 3

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

Completed
NCT00115375Phase 2

Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6